{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:12:33Z","timestamp":1766182353137,"version":"3.41.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["K08EY030924"],"award-info":[{"award-number":["K08EY030924"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>Current treatments for retinoblastoma facilitate globe salvage but can result in vitreoretinal disorders that may require surgery. There is controversy on surgical approaches in eyes with retinoblastoma. Here, we describe a transcorneal vitrectomy approach that avoids the use of chemotherapy or cryotherapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Retrospective chart review was performed on five consecutive patients with regressed retinoblastoma for &gt;12 months (Group D\/ct2b) at Children's Hospital Los Angeles who had vitrectomy between November 2022 and December 2023.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Five patients underwent eight vitrectomies for various indications including intraocular lens fibrosis, vitreous hemorrhage, cataract, retinal detachment, and silicone oil removal. Mean age at first vitrectomy was 6.2 years (range: 2\u20139 years); mean time from last retinoblastoma treatment was 50.4 months (range: 20\u201382 months). Radially oriented corneal incisions were made with the 23-G or 25-G trocar system, and the Versa HD LenZ (Oculus) was used with the RESIGHT (Zeiss) for top-down visualization. Neither chemotherapy nor cryotherapy was used. Wounds were sutured parallel to the limbus with 10-0 polyglactin 910 suture (Vicryl, Ethicon), and a final water rinse was performed to lyse any potential retinoblastoma cells. Surgical objectives were achieved, vision remained stable, and no retinoblastoma spread was noted with a mean follow-up of 7.6 months (range: 3\u201312 months).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This vitrectomy technique for eyes with regressed retinoblastoma permits top-down viewing with the Versa HD LenZ. Radial placement of corneal wounds avoids suturing through the uveal tract, and a postsurgical water rinse lyses any retinoblastoma cells. This approach may obviate the need for chemotherapeutics or cryotherapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004178","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T21:13:03Z","timestamp":1718313183000},"page":"2196-2201","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Transcorneal Vitrectomy In Eyes With Regressed Retinoblastoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Yicheng K.","family":"Bao","sequence":"first","affiliation":[{"name":"Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisella M.","family":"Sanchez","sequence":"additional","affiliation":[{"name":"The Vision Center, Department of Surgery, Children's Hospital Los Angeles, Los Angeles, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Lee","sequence":"additional","affiliation":[{"name":"Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California; and"},{"name":"The Vision Center, Department of Surgery, Children's Hospital Los Angeles, Los Angeles, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse L.","family":"Berry","sequence":"additional","affiliation":[{"name":"Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California; and"},{"name":"The Vision Center, Department of Surgery, Children's Hospital Los Angeles, Los Angeles, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7275-6980","authenticated-orcid":false,"given":"Aaron","family":"Nagiel","sequence":"additional","affiliation":[{"name":"Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California; and"},{"name":"The Vision Center, Department of Surgery, Children's Hospital Los Angeles, Los Angeles, California."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.3390\/jcm10225421","article-title":"Changes in treatment patterns and globe salvage rate of advanced retinoblastoma in Korea: efficacy of intra-arterial chemotherapy","volume":"10","author":"Lee","year":"2021","journal-title":"J Clin Med"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000509080","article-title":"Intravitreal melphalan for retinoblastoma: the impact of toxicity on recurrence and ultimate globe salvage","volume":"6","author":"Berry","year":"2020","journal-title":"Ocul Oncol Pathol"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/bjophthalmol-2019-313985","article-title":"Episcleral brachytherapy for retinoblastoma","volume":"104","author":"Echegaray","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/archopht.119.11.1613","article-title":"Intraocular surgery after treatment of retinoblastoma","volume":"119","author":"Honavar","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1186\/s12885-020-07314-1","article-title":"Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma","volume":"20","author":"Yu","year":"2020","journal-title":"BMC Cancer"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00432-022-04466-4","article-title":"The survival analysis and feasibility study of Pars Plana Vitrectomy (PPV) in the treatment of retinoblastoma","volume":"149","author":"Mou","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ophtha.2017.10.015","article-title":"Pars plana vitrectomy and endoresection of refractory intraocular retinoblastoma","volume":"125","author":"Zhao","year":"2018","journal-title":"Ophthalmology"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"101367","DOI":"10.1016\/j.ajoc.2022.101367","article-title":"Pars plana vitrectomy for vitreoretinal complications in only seeing eyes after treatment for retinoblastoma","volume":"25","author":"Nishida","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.5301\/ejo.5000683","article-title":"Intraocular surgery with melphalan irrigation for vitreous hemorrhage in an only eye with retinoblastoma","volume":"26","author":"Yarovoy","year":"2015","journal-title":"Eur J Ophthalmol"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2016.12.015","article-title":"Efficacy and toxicity of intravitreous chemotherapy for retinoblastoma: four-year experience","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bjophthalmol-2013-303885","article-title":"Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review","volume":"98","author":"Smith","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1097\/IAE.0000000000002746","article-title":"Visual and anatomic outcomes of pediatric endoscopic vitrectomy in 326 cases","volume":"40","author":"Nagiel","year":"2020","journal-title":"RETINA"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1097\/01.iae.0000244289.01875.78","article-title":"Pars plana vitrectomy in eyes treated for retinoblastoma","volume":"26","author":"Warden","year":"2006","journal-title":"Retina"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/S0161-6420(98)91139-3","article-title":"Surgical repair of rhegmatogenous retinal detachment after treatment for retinoblastoma","volume":"105","author":"Baumal","year":"1998","journal-title":"Ophthalmology"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/archopht.123.7.1008","article-title":"Intraocular surgery after treatment of germline retinoblastoma","volume":"123","author":"Moshfeghi","year":"2005","journal-title":"Arch Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:00:41Z","timestamp":1749142841000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004178","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"type":"print","value":"0275-004X"},{"type":"electronic","value":"1539-2864"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}